Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis

NCT01981551 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

Desmoid Tumors
Aggressive Fibromatosis

Interventions

DRUG: PF-03084014

Sponsor

National Cancer Institute (NCI)